Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
Medicine|January 24, 2026
Crizotinib-induced hyperlipidemia in advanced lung adenocarcinoma: A case report and literature reviewShuai Ren, Ruifang ChenJournal of Inflammation Research|November 5, 2025
Immune Landscape in Kidney TransplantationDi Niu, Ruifang Chen, Xinxin PangInternational Journal of Molecular Sciences|July 15, 2026
A CAF-Associated Stromal Remodeling Signature Links Immune Exclusion to Exhaustion-Prone CD8+ T-Cell Dysfunction in High-Grade Serous Ovarian CancerYang Bai, Ruifang Chen, Xin LuBMC Genomics|December 15, 2023
Comparative genomics analysis of Streptococcus iniae isolated from Trachinotus ovatus: novel insight into antimicrobial resistance and virulence differentiationXiangying Xiong, Ruifang Chen, Junxiang LaiZhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|December 10, 2016
[Effect of NLRP3 inflammasome on vascular diseases]Zeng Cao, Yapei Li, Ruifang Chen, et al.Cancer Medicine|August 20, 2018
Survival effect of different lymph node staging methods on ovarian cancer: An analysis of 10 878 patientsJieyu Wang, Jun Li, Ruifang Chen, et al.BMC Infectious Diseases|September 2, 2025
Diagnostic value of Serum Amyloid A (SAA) in HIV-associated pulmonary infections and its correlation with inflammatory markersRuifang Chen, Shuai Ren, Haicheng Tang, et al.Archives of Gynecology and Obstetrics|September 5, 2020
The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumorsJieyu Wang, Ruifang Chen, Jun Li, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 30, 2018
Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysisJieyu Wang, Jun Li, Ruifang Chen, et al.Journal of Ovarian Research|July 29, 2017
A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumorsNing Zhang, Ruifang Chen, Keqin Hua, et al.Pageof 8